Obesity can increase the risk of many chronic diseases including type 2 diabetes, heart disease and certain cancers
A dedicated Phase 2b trial specifically investigating retatrutide in patients with MASLD and metabolic dysfunction-associated steatohepatitis (MASH) the more advanced inflammatory form of the condition is currently ongoing (see ClinicalTrials.gov for registered study identifiers)
Juvederm Ultra Plus may suit clients who want more noticeable volume, though the amount and placement should be conservative when the lips already have fullness
Resolution of inflammation: mechanisms and opportunity for drug development
With the demand for GLP-1 receptor agonists like semaglutide reaching unprecedented levels across Florida, from Jacksonville to Miami, patients are increasingly encountering compounded alternatives due to persistent national shortages of brand-name products
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
